PPARγ agonist ameliorates LSECs activation and inflammation [92]; while PPARβ/δ and PPARα agonists induce ICAM-1 expression in non-stimulated ECs playing an important role in liver fibrosis [93]. The gene discussed is PPARG; the disease is Hepatic fibrosis.